# Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine

> **NCT05760976** · NA · UNKNOWN · sponsor: **Yangzhou University** · enrollment: 90 (estimated)

## Conditions studied

- Fasciculation
- Succinylcholine

## Interventions

- **DRUG:** Cisatracurium

## Key facts

- **NCT ID:** NCT05760976
- **Lead sponsor:** Yangzhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760976, "Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05760976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*